Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B W Van Oosten

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Rheumatology|September 19, 2008
Axonal neuropathy with prolonged sulphasalazine useM Liedorp, A E Voskuyl, B W Van Oosten
Nederlands Tijdschrift Voor Geneeskunde|August 26, 2004
[New diagnostic criteria for multiple sclerosis in clinical practice]B W Van Oosten, F Barkhof, C H Polman
Drugs|February 1, 1995
Multiple sclerosis therapy. A practical guideB W van Oosten, L Truyen, F Barkhof, et al.
Drugs|November 7, 1998
Choosing drug therapy for multiple sclerosis. An updateB W van Oosten, L Truyen, F Barkhof, et al.
Multiple Sclerosis and Related Disorders|March 23, 2019
High work absence around time of diagnosis of multiple sclerosis is associated with fatigue and relapse rateD Doesburg, A Vennegoor, B M J Uitdehaag, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2004
Multiple sclerosis following treatment with a cannabinoid receptor-1 antagonistB W van Oosten, J Killestein, E M H Mathus-Vliegen, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 3, 1996
[Problems in weaning from artificial ventilation: 'motor neuron disease']B W van Oosten, E C van Gorp, D P Brandjes, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 22, 2004
[Eyelid drooping: diagnosis on the basis of an algorithm]B W van Oosten, C J de Langen, G Tissingh, et al.
Archives of Neurology|June 17, 1998
Increased production of tumor necrosis factor alpha, and not of interferon gamma, preceding disease activity in patients with multiple sclerosisB W van Oosten, F Barkhof, P E Scholten, et al.
Multiple Sclerosis and Related Disorders|February 17, 2020
A tumefactive demyelinating lesion in a person with MS after five years of fingolimodL Jeung, L M G Smits, E L J Hoogervorst, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Rheumatology|September 19, 2008
Axonal neuropathy with prolonged sulphasalazine useM Liedorp, A E Voskuyl, B W Van Oosten
Nederlands Tijdschrift Voor Geneeskunde|August 26, 2004
[New diagnostic criteria for multiple sclerosis in clinical practice]B W Van Oosten, F Barkhof, C H Polman
Drugs|February 1, 1995
Multiple sclerosis therapy. A practical guideB W van Oosten, L Truyen, F Barkhof, et al.
Drugs|November 7, 1998
Choosing drug therapy for multiple sclerosis. An updateB W van Oosten, L Truyen, F Barkhof, et al.
Multiple Sclerosis and Related Disorders|March 23, 2019
High work absence around time of diagnosis of multiple sclerosis is associated with fatigue and relapse rateD Doesburg, A Vennegoor, B M J Uitdehaag, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2004
Multiple sclerosis following treatment with a cannabinoid receptor-1 antagonistB W van Oosten, J Killestein, E M H Mathus-Vliegen, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 3, 1996
[Problems in weaning from artificial ventilation: 'motor neuron disease']B W van Oosten, E C van Gorp, D P Brandjes, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 22, 2004
[Eyelid drooping: diagnosis on the basis of an algorithm]B W van Oosten, C J de Langen, G Tissingh, et al.
Archives of Neurology|June 17, 1998
Increased production of tumor necrosis factor alpha, and not of interferon gamma, preceding disease activity in patients with multiple sclerosisB W van Oosten, F Barkhof, P E Scholten, et al.
Multiple Sclerosis and Related Disorders|February 17, 2020
A tumefactive demyelinating lesion in a person with MS after five years of fingolimodL Jeung, L M G Smits, E L J Hoogervorst, et al.
Pageof 3